| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Anemia | |||||
| Non-Myeloid Malignancies | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Neoplasms | |||||
| 3 | More general conditions related to this trial | ||||
| Hematologic Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| Darbepoetin alfa SC | |||||
| Darbepoetin alfa IV | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Darbepoetin alfa | |||||
| 6 | More general drug interventions related to this trial | ||||
| Hematinics | |||||
| Hematologic Agents | |||||
| Pharmacologic Actions | |||||
| Therapeutic Uses | |||||
| 7 | Sponsors listed in this trial | ||||
| Amgen | |||||
|
